Researchers have developed an antibody that prevents blood clots without causing bleeding, a risk associated with current anticoagulant drugs. This material relates to a paper that appeared in the Aug. 24, 2016 issue of Science Translational Medicine, published by AAAS. The paper, by T. David at University of California, San Francisco in San Francisco, CA, and colleagues was titled, "Factor XIa-specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.